ENTA
EnantaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Composite grade C from latest DB weights. Momentum 68.9 / Value 41.1
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +7.7.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
69
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $21.57
Why
Momentum69 · Δ7d +7.7
Value41 · Δ7d +0.0
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
69
40% active weight
Current posture
7d trendSoftening
Δ7d
+7.7
Δ21d
+53.8
Value
41
60% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 68.9 / Value 41.1
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$382.67M
Beta
0.99
Shares Out
29.08M
P/E (TTM) · Derived
-3.4
P/S (TTM)
6.15
P/FCF (TTM) · Derived
-60.12
Rev YoY
+15.0%
EPS YoY
-57.5%
Gross Margin
+92.9%
Op Margin
-130.7%
Net Debt
$12.19M
Current Ratio
3.84
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology